Abstracts (HTML) List of Authors

Ma, S

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Maass, N

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

Mackensen, A

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Mahner, S

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Maurer, J

KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

Meier, S

Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums

Metzger, E

KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

Milde-Langosch, K

Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients

Müller, C

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom

Müller, V

Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Mustea, A

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma